1. World Health Organization. Preventing suicide A global imperative. Geneva: World Health Organisation; 2014.
2. Office for National Statistics. Suicides in the UK. Newport: Office for National Statistics; 2018.
3. The Mental Health Taskforce. The five year forward view for mental health. London: NHS England; 2016.
4. HM Government. Preventing suicide in England: Third progress report on the cross-government outcomes strategy to save lives. London: HM Government; 2017.
5. Health Select Committee. Suicide prevention. London: House of Commons; 2017.
6. Public Health England. Local suicide prevention planning. London: Public Health England; 2016.
7. Scottish Government. Scotland’s Suicide Prevention Action Plan: Every Life Matters. Edinburgh: Scottish Government; 2018.
8. National Collaborating Centre for Mental Health. Self-harm and Suicide Prevention Competence Framework: Adults and older adults. London: National Collaborating Centre for Mental Health; 2018.
9. Pharmaceutical Services Negotiating Committee. About community pharmacy [Internet]. 2018 [cited 16 Oct 2018]. Available from: https://psnc.org.uk/psncs-work/about-community-pharmacy
10. The National Health Service Act 2006. The Pharmaceutical Services (Advanced and Enhanced Services)(England) Directions 2013, (2006).
11. NHS England. Quality Payments: Guidance for the February 2019 Review Point. London: NHS England; 2018.
12. National Institute for Health and Care Excellence and Public Health England. NG105 Preventing suicide in community and custodial settings. London: National Institute for Health and Care Excellence; 2018.
13. Murphy A, Hillier K, Ataya R, Thabet P, Whelan A, O’Reilly C et al. A scoping review of community pharmacists and patients at risk of suicide. Can Pharm J(Ott). 2017;150:366–79.
14. Murphy A, Ataya R, Himmelman D, O’Reilly C, Rosen A, Salvador-Carulla L et al. Community pharmacists’ experiences and people at risk of suicide in Canada & Australia: a thematic analysis. Soc Psychiatry Psychiatr Epidemiol. 2018; 53(11):1173–84. doi: 10.1007/s00127-018-1553-7 29936597
15. Carpenter D, Lavigne J, Colmenares E, Falbo K, Mosley S. Community pharmacy staff interactions with patients who have risk factors or warning signs of suicide. Res Soc Adm Pharm. 2019;[in press].
16. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
17. Boyatzis R. Transforming qualitative information: Thematic analysis and code development. London: Sage; 1998.
18. Samaritans. Suicide reporting-additional points to consider [Internet]. 2016 [cited 21 Jan 2019]. Available from: http://www.samaritans.org/media-centre/media-guidelines-reporting-suicide/suicide-reporting-additional-points-consider.
19. Murphy AL, Gardner DM, Jacobs LM. Patient care activities by community pharmacists in a capitation funding model mental health and addictions program. BMC Psychiatry. 2018;18(1):192. doi: 10.1186/s12888-018-1746-3 29898682
20. Hindi AM, Schafheutle EI, Jacobs S. Patient and public perspectives of community pharmacies in the United Kingdom: A systematic review. Health Expect. 2018;21(2):409–28. doi: 10.1111/hex.12639 29114971
21. GPhC. Future Pharmacists: Standards for the initial education and training of pharmacists. London: GPhC; 2011.
22. Carpenter D, Lavigne J, Roberts C, Zacher J, Colmenares EW. A Review of Suicide Prevention Programs and Training Policies for Pharmacists. J Am Pharm Assoc. 2018;58(5):522–29.
23. Matt Adler suicide assessment, treatment, and management training act of 2012, (2012)
24. Leavey G, Mallon S, Rondon-Sulbara J, Galway K, Rosato M, Hughes L. The failure of suicide prevention in primary care: family and GP perspectives—a qualitative study. BMC Psychiatry. 2017;17:369. doi: 10.1186/s12888-017-1508-7 29157221
25. Murray R. Community Pharmacy Clinical Services Review. London: Kings Fund; 2016.
26. Anderson C, Kirkpatrick S, Ridge D, Kokanovic R, Tanner C. Starting antidepressant use: a qualitative synthesis of UK and Australian data. BMJ Open. 2015;5(12).
27. Firth H, Todd A, Bambra C. Benefits and barriers to the public health pharmacy: a qualitative exploration of providers’ and commissioners’ perceptions of the Healthy Living Pharmacy framework. Perspect Public Health. 2015;135(5):251–56. doi: 10.1177/1757913915579457 25868465
28. Lavigne JE, King DA, Lu NJ, Knox KL, Kemp JE. Pharmacist and pharmacy staff knowledge, attitudes and motivation to refer patients for suicide risk assessment: lessons from operation S.A.V.E. In: Lavigne JE, editor. Frontiers in Suicide Risk. US: Nova Science Publishers, Inc; 2012.
29. Murphy AL, O’Reilly CL, Ataya R, Doucette SP, Martin-Misener R, Rosen A et al. A survey of Canadian and Australian pharmacists’ stigma of suicide. SAGE Open Med. 2019;7:2050312118820344. doi: 10.1177/2050312118820344 30728964
30. Carrr MJ, Ashcroft DM, Kontopantelis E, Awenat Y, Cooper J, Chew-Graham C et al. The epidemiology of self-harm in a UK-wide primary care patient cohort, 2001–2013. BMC Psychiatry. 2016;16(1).
31. NHS England. Hospital Accident and Emergency Activity—2017–18 [Internet]. 2018 [cited 22 Sept 2018]. Available from: https://digital.nhs.uk/data-andinformation/publications/statistical/hospital-accident-emergency-activity/2017-1831
32. Office for National Statistics. Deaths related to drug poisoning in England and Wales: 2017 registrations. Newport: Office for National Statistics; 2018